CD274 and leiomyosarcoma: Consistent with previous studies, we show that PD-L1 (+) was commonly observed in UPS, angiosarcoma, and leiomyosarcoma, and that PD-L1 (+) staining independently correlated with poor efficacy of pazopanib treatment.